Results 111 to 120 of about 23,362 (196)

Quality management in hospitals: analysis of the prescribing practice of cardiovascular medicines [PDF]

, 2014
The goal of this study is to analyse the prescribing practice and risk of drug related errors in a Cardiology clinic of University Hospital. Semistructured open-ended interview aiming to reveal the risk of potential errors was performed with ...
Angelovska, Bistra, Georgieva, Svetla, Petrova, Guenka, Savova, Alexandra, Stoimenova, Assena   +4 more
core  

Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects

Drug Design, Development and Therapy, 2012
Raymond R Tjandrawinata,1 Effi Setiawati,2 Danang Agung Yunaidi,2 Iwan Dwi Santoso,2 Arini Setiawati,3 Liana W Susanto11Dexa Laboratories of Biomolecular Sciences (DLBS), Cikarang, Indonesia; 2Bioavailability and Bioequivalence Laboratory, Equilab ...
Tjandrawinata RR, Setiawati E, Yunaidi DA, Santoso ID, Setiawati A, Susanto LW   +5 more
doaj  

Beta-adrenoЬlockers in patients with chronic heart failure and chronic obstructive pulmonary disease

Кардиоваскулярная терапия и профилактика, 2008
Aim. To compare clinical effectiveness and safety of bisoprolol and metoprolol as a part of basis chronic heart failure (CHF) therapy in patients with coexisting chronic obstructive pulmonary disease (COPD).Material and methods.
M. E. Statsenko, D. A. Ivanova, O. E. Sporova, S. V. Belenkova   +3 more
doaj  

CARDIO-SELECTIVE Β-BLOCKER BISOPROLOL IN THE MANAGEMENT OF CORONARY HEART DISEASE

Российский кардиологический журнал, 2011
The article is focussed on the role of a modern selective β-blocker bisoprolol in the management of coronary heart disease (CHD). The benefits of bisoprolol therapy are demonstrated for both clinical improvement and reduction in the risk of ...
V. P. Lupanov
doaj  

Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients. [PDF]

ERJ Open Res
Bradbury TF, Martin A, Hancox RJ, Chang CL, Beasley R, Wrobel JP, McDonald VM, Dobler CC, Yang IA, Farah CS, Cochrane B, Hillis GS, Polak Scowcroft C, Aggarwal A, Ranasinha C, Galgey S, Jenkins CR.   +16 more
europepmc   +1 more source

Poorer Clinical Outcomes and Longer Hospitalization with Beta Blocker Discontinuation in Acute Decompensated Heart Failure Wet and Warm: A Retrospective Study. [PDF]

Hosp Pharm
Alsagaff MY, Afrilla D, Jannati D, Nilamsari WP, Maghfirah I, Jaya HP.   +5 more
europepmc   +1 more source

Compounding and stability studies of liquid oral formulations of beta-blockers (bisoprolol, betaxolol, and nadolol) for paediatric patients. [PDF]

J Pharm Pharm Sci
Dubois L, Bouguergour C, Paoli-Lombardo R, Castera-Ducros C, Jean C, Fuchs M, Vanelle P, Rathelot P, Terme T, Curti C.   +9 more
europepmc   +1 more source

The prognostic impact of beta blockers in ischemic heart failure: time for a paradigm shift? [PDF]

Heart Fail Rev
Castiello DS, Calvelli P, Anniballo A, Romano LR, Polimeni A, Curcio A.   +5 more
europepmc   +1 more source

New-Onset Guttate Psoriasis Induced by Durvalumab: Potential Role of Bisoprolol. [PDF]

Cureus
Tshika Wa Kabeya O, Kaziga Wiyaou DD, Moustaghfir I.   +2 more
europepmc   +1 more source

The Vulnerable Phase of Heart Failure [PDF]

, 2018
Butler, Javed, Chioncel, Ovidiu, Collins, Sean, Gracia, Ely, Pang, Peter, Singh, Prabhjot   +5 more
core   +1 more source